期刊
JOURNAL OF GASTROENTEROLOGY
卷 44, 期 6, 页码 630-634出版社
SPRINGER JAPAN KK
DOI: 10.1007/s00535-009-0051-9
关键词
Primary biliary cirrhosis; Symptoms; Ursodeoxycholic acid; gamma-Glutamyl transpeptidase
资金
- Study Group for Intractable Liver Diseases
- Japanese Ministry of Health, Labor and Welfare of Japan
Among patients with asymptomatic primary biliary cirrhosis (a-PBC), a substantial portion ultimately develop symptoms suggestive of liver injury. Prognostic variables to distinguish patients likely to become symptomatic from patients who will remain asymptomatic need to be identified. We examined the impact of biochemical response to ursodeoxycholic acid in the development of symptoms in patients with a-PBC. Subjects comprised 83 patients with a-PBC treated using ursodeoxycholic acid (UDCA). All patients were followed regularly every 1-3 months. Response to treatment with UDCA was defined as a decrease in gamma-glutamyl transpeptidase (GGT) a parts per thousand yen70% of pretreatment or normal levels from 6 months after start of treatment. During the follow-up period (62.1 +/- A 52.7 months), 12 patients (14.5%) developed liver-related symptoms. Incidence of the development of liver-related symptoms was significantly higher in UDCA non-responders than in responders (p < 0.001). Multivariate analysis showed that response to UDCA (improvement of GGT) represents an independent factor for predicting symptom development in patients with a-PBC. Patients with a-PBC showing lack of biochemical response to UDCA by 6 months after treatment commencement should be considered for further treatments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据